BuccheriGF, ViolanteB, SartorisAM, FerrignoD, CurcioA, VolaF.Clinical value of multiple biomarker assay in patients with bronchogenic carcinoma. Cancer1986; 57: 2389–96.
2.
BuccheriGF, FerrignoD.Usefulness of tissue polypeptide antigen in staging, monitoring and prognosis of lung cancer. Chest1988; 93: 565–70.
3.
NemotoT, CostantineR, ChuTM. Human tissue polypeptide antigen in breast cancer. J Natl Cancer Instit1979; 63: 1247–350.
4.
BjorklundB, BjorklundV.Antigenicity of pooled human malignant and normal tissue by cyto-immunological technique: Presence of an insoluble heat-labile tumor antigen. Int Arch Allergy1957; 10: 153–83.
5.
BjorklundB.Tissue polypeptide antigen (TPA): biology, biochemistry, improved assay methodology, clinical significance in cancer and other conditions, and future outlook. In: SchonfeldH, ed. Laboratory testing for cancer, antibiotics, chemotherapy. Basel: Karger, 1978; 2: 16–31.
6.
BjorklundB, BjorklundV.Biochemische und morphologische Grundlagen von TPA: Fortschritte in Richtung auf einem allegemeinen Marker fur aktive tumoren durch monoclonale kartierung. In: LuthgensM, SchlegelG, eds. Tumor markersystem CEA-TPA. Tumor Diagnostik Verlag, 1987; 14–30.
7.
BjorklundB, OehrP, BiersackHJ, BjorklundV, BrunkenerM, GronlundG.Assay of TPA by RIA, immunohistochemistry and localization in vivo in the follow up of cancer using poly and monoclonal antibodies. Invited presentation at the 4th International Conference on Human Tumor Markers. New York City, USA, Aug. 25–28, 1987.
8.
MillerAB, HoogstratenB, StaquetM, WinklerA.Reporting results of cancer treatment. Cancer1981; 47: 207–14.
9.
BjorklundB, BjorklundV, BrunkenerM, GronlundH, BackM.The enigma of human tumor marker: TPA revisited. In: CiminoF, BirkmayerGD, KlavinsJV, PimentelE, SalvatoreF, eds. Human Tumor Markers. Berlin: Walter de Gruyter, 1987; 169–80.
10.
BjorklundB, BjorklundV.The proliferation marker theory with TPS as a model. Invited lecture at the 7th International Conference on Human Tumor Markers, held by the international Academy of Tumor Marker Oncology (IATMO), Kiev, USSR, September 10–14, 1990.